Jun 23, 2020
STORM Therapeutics Appoints Dr. Josefin-Beate Holz as Chief Medical Officer
Jun 22, 2020
Imagia Partners with Illumina to Scale Discoveries Across Genomic and Clinical Data
Jun 22, 2020
Agenus and Betta Pharmaceuticals Enter Into a License Agreement for Balstilimab and Zalifrelimab in Greater China
Jun 22, 2020
Regeneron Announces the 2020 Winners of the Regeneron Prize for Creative Innovation
Jun 22, 2020
Rare Disease Diagnostics: Technologies and Global Markets
Jun 22, 2020
Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19
Jun 22, 2020
Amgen Is Supporting Advancement Of AMG 634 For Global Health Diseases In Developing Countries
Jun 19, 2020
Biomarker Technologies Market Size Hit US$ 117,853 Mn By 2027
Jun 19, 2020
Roche receives FDA approval for cobas EZH2 Mutation Test as a companion diagnostic for patients with follicular lymphoma
Jun 19, 2020
TBRC Reports: Production of New Insulin Biosimilars is The Latest Trend in The Market, as Seen With Biocon's Newly FDA Approved Semglee
Jun 19, 2020
Global Market Outlook for the Coronavirus Diagnostics Market to 2027
Jun 18, 2020
Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing
Jun 18, 2020
/R E P E A T -- New Wave Holdings Corp Appoints Dr. Carolyn Myers As VP Of Commerical Development/
Jun 18, 2020
Proposal for a New Board Member to be Elected at the Extraordinary General Meeting on July 3, 2020
Jun 17, 2020
Akcea Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
Jun 17, 2020
CORAT Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program
Jun 17, 2020
Leukemia Therapeutics Markets, 2015-2025 - Size by Value & Volume, Trends & Developments, Competitive Landscape
Jun 17, 2020
Halozyme To Participate In The BMO 2020 Prescriptions For Success Healthcare Conference
Jun 17, 2020
Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and Country, with COVID-19 Impact & Forecasting Analysis
Jun 17, 2020
New Wave Holdings Corp Appoints Dr. Carolyn Myers As VP Of Commerical Development